Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease

NeuroImage

Volumn 55, Issue 1, 2011, Pages 32-38

  Leskovjan, Andreana C ^a,b   Kretlow, Ariane ^b,f   Lanzirotti, Antonio ^c   Barrea, Raul ^d   Vogt, Stefan ^e   Miller, Lisa M ^a,b  

^a St Francis Hospital The Heart Center   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

^d ILLINOIS INSTITUTE OF TECHNOLOGY   (United States)

^e ARGONNE NATIONAL LABORATORY   (United States)

^f FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Alzheimer's disease; Amyloid plaques; Copper; Cortex; Hippocampus; Imaging; Iron; Transgenic mice; X ray fluorescence; Zinc

Indexed keywords

COPPER; IRON; ZINC;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; EARLY DIAGNOSIS; FEMALE; HIPPOCAMPUS; IRON METABOLISM; MOUSE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; X RAY FLUORESCENCE;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; IRON; MALE; MICE; MICE, MUTANT STRAINS; PLAQUE, AMYLOID; TISSUE DISTRIBUTION;

EID: 78951481093     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.11.073     Document Type: Article

References (42)

1. Barrea R.A., Gore D., Kujala N., Karanfil C., Kozyrenko S., Heurich R., Vukonich M., Huang R., Paunesku T., Woloschak G., Irving T.C. Fast-scanning high flux microprobe for biological X-ray fluorescence microscopy and microXAS. J. Synchrotron Radiat. 2010, 17:522-529.
2. Bartzokis G., Sultzer D., Cummings J., Holt L.E., Hance D.B., Henderson V.W., Mintz J. In vivo evaluation of brain iron in Alzheimer disease using magnetic resonance imaging. Arch. Gen. Psychiatry 2000, 57:47-53.
3. Bartzokis G., Tishler T.A., Shin I.S., Lu P.H., Cummings J.L. Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases. Ann. NY Acad. Sci. 2004, 1012:224-236.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
5. Brass S.D., Chen N.K., Mulkern R.V., Bakshi R. Magnetic resonance imaging of iron deposition in neurological disorders. Top. Magn. Reson. Imaging 2006, 17:31-40.
6. Bush A.I. The metallobiology of Alzheimer's disease. Trends Neurosci. 2003, 26:207-214.
7. Connor J.R., Snyder B.S., Beard J.L., Fine R.E., Mufson E.J. Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease. J. Neurosci. Res. 1992, 31:327-335.
8. Cuajungco M.P., Lees G.J. Zinc and Alzheimer's disease: is there a direct link?. Brain Res. Brain Res. Rev. 1997, 23:219-236.
9. Deibel M.A., Ehmann W.D., Markesbery W.R. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress. J. Neurol. Sci. 1996, 143:137-142.
10. El Tannir El Tayara N., Delatour B., Le Cudennec C., Guegan M., Volk A., Dhenain M. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 2006, 22:199-208.
11. Garcia-Alloza M., Robbins E.M., Zhang-Nunes S.X., Purcell S.M., Betensky R.A., Raju S., Prada C., Greenberg S.M., Bacskai B.J., Frosch M.P. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol. Dis. 2006, 24:516-524.
12. Gelman N., Gorell J.M., Barker P.B., Savage R.M., Spickler E.M., Windham J.P., Knight R.A. MR imaging of human brain at 3.0T: preliminary report on transverse relaxation rates and relation to estimated iron content. Radiology 1999, 210:759-767.
13. Giannakopoulos P., Hof P.R., Michel J.P., Guimon J., Bouras C. Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Brain Res. Rev. 1997, 25:217-245.
14. Griffiths P.D., Dobson B.R., Jones G.R., Clarke D.T. Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. Brain 1999, 122:667-673.
15. Guntern R., Bouras C., Hof P.R., Vallet P.G. An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease. Experientia 1992, 48:8-10.
16. Haacke E.M., Cheng N.Y., House M.J., Liu Q., Neelavalli J., Ogg R.J., Khan A., Ayaz M., Kirsch W., Obenaus A. Imaging iron stores in the brain using magnetic resonance imaging. Magn. Reson. Imaging 2005, 23:1-25.
17. Helpern J.A., Jensen J., Lee S.P., Falangola M.F. Quantitative MRI assessment of Alzheimer's disease. J. Mol. Neurosci. 2004, 24:45-48.
18. House M.J., St Pierre T.G., Foster J.K., Martins R.N., Clarnette R. Quantitative MR imaging R2 relaxometry in elderly participants reporting memory loss. Am. J. Neuroradiol. 2006, 27:430-439.
19. Jankowsky J.L., Slunt H.H., Ratovitski T., Jenkins N.A., Copeland N.G., Borchelt D.R. Co-expression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol. Eng. 2001, 17:157-165.
20. Jones L.C., Beard J.L., Jones B.C. Genetic analysis reveals polygenic influences on iron, copper, and zinc in mouse hippocampus with neurobiological implications. Hippocampus 2008, 18:398-410.
21. Lee J.Y., Cole T.B., Palmiter R.D., Suh S.W., Koh J.Y. Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice. Proc. Natl Acad. Sci. USA 2002, 99:7705-7710.
22. Lee J.Y., Mook-Jung I., Koh J.Y. Histochemically reactive zinc in plaques of the Swedish mutant β-amyloid precursor protein transgenic mice. J. Neurosci. 1999, 19:RC10.
23. Leskovjan A.C., Lanzirotti A., Miller L.M. Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease. Neuroimage 2009, 47:1215-1220.
24. Linkous D.H., Flinn J.M., Koh J.Y., Lanzirotti A., Bertsch P.M., Jones B.F., Giblin L.J., Frederickson C.J. Evidence that the ZNT3 protein controls the total amount of elemental zinc in synaptic vesicles. J. Histochem. Cytochem. 2008, 56:3-6.
25. Lovell M.A., Robertson J.D., Teesdale W.J., Campbell J.L., Markesbery W.R. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 1998, 158:47-52.
26. Magaki S., Raghavan R., Mueller C., Oberg K.C., Vinters H.V., Kirsch W.M. Iron, copper, and iron regulatory protein 2 in Alzheimer's disease and related dementias. Neurosci. Lett. 2007, 418:72-76.
27. Masters C.L., Cappai R., Barnham K.J., Villemagne V.L. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. J. Neurochem. 2006, 97:1700-1725.
28. Michaeli S., Oz G., Sorce D.J., Garwood M., Ugurbil K., Majestic S., Tuite P. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov. Disord. 2007, 22:334-340.
29. Miller L.M., Wang Q., Telivala T.P., Smith R.J., Lanzirotti A., Miklossy J. Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with β-amyloid deposits in Alzheimer's disease. J. Struct. Biol. 2006, 155:30-37.
30. Paunesku T., Vogt S., Maser J., Lai B., Woloschak G. X-ray fluorescence microprobe imaging in biology and medicine. J. Cell. Biochem. 2006, 99:1489-1502.
31. Price J.L., Morris J.C. Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease. Ann. Neurol. 1999, 45:358-368.
32. Religa D., Strozyk D., Cherny R.A., Volitakis I., Haroutunian V., Winblad B., Naslund J., Bush A.I. Elevated cortical zinc in Alzheimer disease. Neurology 2006, 67:69-75.
33. Schenck J.F. Magnetic resonance imaging of brain iron. J. Neurol. Sci. 2003, 207:99-102.
34. Schenck J.F., Zimmerman E.A., Li Z., Adak S., Saha A., Tandon R., Fish K.M., Belden C., Gillen R.W., Barba A., Henderson D.L., Neil W., O'Keefe T. High-field magnetic resonance imaging of brain iron in Alzheimer disease. Top. Magn. Reson. Imaging 2006, 17:41-50.
35. Smith M.A., Zhu X., Tabaton M., Liu G., McKeel D.W., Cohen M.L., Wang X., Siedlak S.L., Dwyer B.E., Hayashi T., Nakamura M., Nunomura A., Perry G. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 2010, 19:363-372.
36. Stankiewicz J., Panter S.S., Neema M., Arora A., Batt C.E., Bakshi R. Iron in chronic brain disorders: imaging and neurotherapeutic implications. Neurotherapeutics 2007, 4:371-386.
37. Suh S.W., Jensen K.B., Jensen M.S., Silva D.S., Kesslak P.J., Danscher G., Frederickson C.J. Histochemically-reactive zinc in amyloid plaques, angiopathy, and degenerating neurons of Alzheimer's diseased brains. Brain Res. 2000, 852:274-278.
38. Thomas L.O., Boyko O.B., Anthony D.C., Burger P.C. MR detection of brain iron. Am. J. Neuroradiol. 1993, 14:1043-1048.
39. Trinchese F., Liu S., Battaglia F., Walter S., Mathews P.M., Arancio O. Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice. Ann. Neurol. 2004, 55:801-814.
40. Vogt S. MAPS: a set of software tools for analysis and visualization of 3D X-ray fluorescence data sets. J. Phys. IV 2003, 104:635-638.
41. White A.R., Barnham K.J., Bush A.I. Metal homeostasis in Alzheimer's disease. Expert Rev. Neurother. 2006, 6:711-722.
42. Zhang L.H., Wang X., Zheng Z.H., Ren H., Stoltenberg M., Danscher G., Huang L., Rong M., Wang Z.Y. Altered expression and distribution of zinc transporters in APP/PS1 transgenic mouse brain. Neurobiol. Aging 2008, 31:74-87.